Taj
Pharmaceuticals Limited firmly believes that quality can not
be talked into a product,
but has to exist inherently. Its efforts towards realizing
world-class quality standards.
Taj Pharmaceuticals Limited’s
rapid growth and expansion in the international and domestic
markets led to the commencement of a new formulations
manufacturing facility at Baddi, Himachal Pradesh, in the last
quarter of 2005-06. The upcoming facility, built
to world-class standards, will have capacity to manufacture
2100 mn tablets and
shall become operational in JN 08.
Investment of around 2.35
million USD is also being made to augment the API capacity
in Taj Pharmaceuticals Limited’s existing plant at Maharashtra
.This will ensure supply of quality API for supply of
formulations to the regulated markets, especially USA and EU.
An organisations’
capabilities and intent are strongly reflected in the product
it manufactures. In other words, the manufacturing
competencies and facilities echo truly, the R&D extent and the
ability to implement it for the best of the market it targets.
Taj Pharmaceuticals Limited’s
manufacturing strengths have established it as a producer of
world-class generics, branded generics and a major supplier of
its range of Active Pharmaceutical Ingredients. Taj
Pharmaceuticals Limited has world-class manufacturing
facilities in seven countries namely China, Ireland, India,
Malaysia, Nigeria, USA and Vietnam. Its overseas facilities
are designed to cater to the requirements of the local
regulatory bodies of that country while the Indian facilities
meet the requirements of all International Regulatory
Agencies. Some of the agencies such as MCA-UK, MCC-Sout
Africa, FDA-USA and TGA-Australia, have audited and approved
Taj Pharmaceuticals Limited’s manufacturing facilities for the
compliance with international. Good Manufacturing Practices
and have registered its products for safety, quality and
efficacy. Taj Pharmaceuticals Limited exports raw materials,
intermediates, prescription drugs, OTC products and veterinary
products. Taj Pharmaceuticals Limited also offers technology
for products and processes. Technical know-how/fees received
during the year 2004-05 amounted to Rs.415 million. Taj
Pharmaceuticals Limited's manufacturing facilities have been
approved by the following regulatory authorities: |
|